Kei Akimoto

A Pharmacokinetic Study of MCI-186, a Novel Drug for Cerebrovascular Disease in Elderly and Young Health Subjects.

Shin‐ichi Yokota, Yuji Kumagai, M. Uchiumi et al. · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · 1997 · 19 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +12

Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation Parameters

Kei Akimoto, Ute Klinkhardt, Andreas M. Zeiher et al. · The Journal of Clinical Pharmacology · 2010 · 14 citations

Medicine, Pharmacokinetics, Pharmacology +17

Effect of Ketoconazole on the Pharmacokinetics of the Dipeptidyl Peptidase-4 Inhibitor Teneligliptin: An Open-Label Study in Healthy White Subjects in Germany

Yoshinobu Nakamaru, Yoshiharu Hayashi, Mana Sekine et al. · Clinical Therapeutics · 2014 · 13 citations

Pharmacy, Pharmacokinetics, Pharmacology +7

AUTOINDUCTION OF MKC-963 [(R)-1-(1-CYCLOHEXYLETHYLAMINO)-4-PHENYLPHTHALAZINE] METABOLISM IN HEALTHY VOLUNTEERS AND ITS RETROSPECTIVE EVALUATION USING PRIMARY HUMAN HEPATOCYTES AND CDNA-EXPRESSED ENZYMES

Toshiyuki Shimizu, Kei Akimoto, Takuya Yoshimura et al. · Drug Metabolism and Disposition · 2006 · 13 citations

Medicine, Pharmacokinetics, Pharmacology +13

Investigation of Potential Pharmacokinetic Interactions Between Teneligliptin and Metformin in Steady-state Conditions in Healthy Adults

Yoshinobu Nakamaru, Yoshiharu Hayashi, Martin Davies et al. · Clinical Therapeutics · 2015 · 12 citations

Pharmacy, Pharmacokinetics, Pharmacology +11